BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T'sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P; RESCUE Trial Investigators. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. The Journal of Clinical Endocrinology & Metabolism 2018;103:1224-32. [DOI: 10.1210/jc.2017-02498] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Hirsch IB, Miller E. Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives. Diabetes Technol Ther 2021;23:S72-80. [PMID: 34546085 DOI: 10.1089/dia.2021.0233] [Reference Citation Analysis]
2 Murphy HR, Feig DS, Sanchez JJ, de Portu S, Sale A; CONCEPTT Collaborative Group. Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes. Diabet Med 2019;36:1652-8. [PMID: 31162713 DOI: 10.1111/dme.14046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
3 Chow KW, Kelly DJ, Rieff MC, Skala PA, Kravets I, Charitou MM, Morley EJ, Gupta R, Miller JD. Outcomes and Healthcare Provider Perceptions of Real-Time Continuous Glucose Monitoring (rtCGM) in Patients With Diabetes and COVID-19 Admitted to the ICU. J Diabetes Sci Technol 2021;15:607-14. [PMID: 33435706 DOI: 10.1177/1932296820985263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bratke H, Margeirsdottir HD, Assmus J, Njølstad PR, Skrivarhaug T. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population. Diabetes Ther 2021;12:2571-83. [PMID: 34389930 DOI: 10.1007/s13300-021-01127-6] [Reference Citation Analysis]
5 Ratner RE. Hypoglycemia: New Definitions and Regulatory Implications. Diabetes Technology & Therapeutics 2018;20:S2-50-3. [DOI: 10.1089/dia.2018.0113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
6 Isaacs D, Bellini NJ, Biba U, Cai A, Close KL. Health Care Disparities in Use of Continuous Glucose Monitoring. Diabetes Technol Ther 2021;23:S81-7. [PMID: 34546086 DOI: 10.1089/dia.2021.0268] [Reference Citation Analysis]
7 March CA, Nanni M, Kazmerski TM, Siminerio LM, Miller E, Libman IM. Modern diabetes devices in the school setting: Perspectives from school nurses. Pediatr Diabetes 2020;21:832-40. [PMID: 32249474 DOI: 10.1111/pedi.13015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Massa GG, Gys I, Bevilacqua E, Wijnands A, Zeevaert R. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion. Diabetes Res Clin Pract 2019;152:111-8. [PMID: 31121275 DOI: 10.1016/j.diabres.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Kraaijeveld SR. Continuous Glucose Monitoring as a Matter of Justice. HEC Forum 2021;33:345-70. [PMID: 32440803 DOI: 10.1007/s10730-020-09413-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Préau Y, Galie S, Schaepelynck P, Armand M, Raccah D. Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §. Sensors (Basel) 2021;21:6131. [PMID: 34577338 DOI: 10.3390/s21186131] [Reference Citation Analysis]
11 Battelino T. Continuous Glucose Monitoring Efficacy in Routine Use. J Clin Endocrinol Metab 2018;103:2414-6. [PMID: 29618027 DOI: 10.1210/jc.2018-00275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Bailey TS, Alva S. Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations. Diabetes Technol Ther 2021;23:S5-S11. [PMID: 34546084 DOI: 10.1089/dia.2021.0236] [Reference Citation Analysis]
13 Xia J, Hu S, Xu J, Hao H, Yin C, Xu D. The correlation between glucose fluctuation from self-monitored blood glucose and the major adverse cardiac events in diabetic patients with acute coronary syndrome during a 6-month follow-up by WeChat application. Clin Chem Lab Med 2018;56:2119-24. [PMID: 30016270 DOI: 10.1515/cclm-2018-0220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
14 Alhodaib HI, Alsulihem S. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia. World J Diabetes 2021; 12(11): 1908-1916 [PMID: 34888015 DOI: 10.4239/wjd.v12.i11.1908] [Reference Citation Analysis]
15 Perera R, Oliver N, Wilmot E, Marriott C. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England. Diabet Med 2018;35:1617-8. [DOI: 10.1111/dme.13766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Akturk HK, Garg S. Technological advances shaping diabetes care. Curr Opin Endocrinol Diabetes Obes 2019;26:84-9. [PMID: 30720477 DOI: 10.1097/MED.0000000000000467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
17 Stone JY, Bailey TS. Benefits and limitations of continuous glucose monitoring in type 1 diabetes. Expert Review of Endocrinology & Metabolism 2020;15:41-9. [DOI: 10.1080/17446651.2020.1706482] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Welsh JB. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes. Diabetes Technology & Therapeutics 2018;20:S2-42-9. [DOI: 10.1089/dia.2018.0100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
19 Gill M, Zhu C, Shah M, Chhabra H. Health Care Costs, Hospital Admissions, and Glycemic Control Using a Standalone, Real-Time, Continuous Glucose Monitoring System in Commercially Insured Patients With Type 1 Diabetes. J Diabetes Sci Technol 2018;12:800-7. [PMID: 29737202 DOI: 10.1177/1932296818777265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
20 Ajjan R, Slattery D, Wright E. Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners. Adv Ther 2019;36:579-96. [PMID: 30659511 DOI: 10.1007/s12325-019-0870-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
21 Gavin JR, Bailey C. Real-World Studies Support Use of CGM in Type 1 and Type 2 Diabetes Independently of Treatment Regimen. Diabetes Technol Ther 2021. [PMID: 34165343 DOI: 10.1089/dia.2021.0211] [Reference Citation Analysis]
22 Galindo RJ, Parkin CG, Aleppo G, Carlson AL, Kruger DF, Levy CJ, Umpierrez GE, McGill JB. What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes Technol Ther 2021. [PMID: 33844588 DOI: 10.1089/dia.2021.0107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Reyes-García R, Mezquita-Raya P, Moreno-Pérez Ó, Muñoz-Torres M, Merino-Torres JF, Márquez Pardo R, Jódar-Gimeno E, Escalada San Martín J, Gargallo-Fernández M, Soto-Gonzalez A, González Pérez de Villar N, Bellido Guerrero D, Gómez-Peralta F, de Luis Román D, López de la Torre Casares M; Spanish Society of Endocrinology and Nutrition (SEEN). Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:270-6. [PMID: 34266639 DOI: 10.1016/j.endien.2021.06.004] [Reference Citation Analysis]
24 De Ridder F, den Brinker M, De Block C. The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education. Ther Adv Endocrinol Metab 2019;10:2042018819865399. [PMID: 31384420 DOI: 10.1177/2042018819865399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
25 Yamamoto JM, Murphy HR. Technology and Pregnancy. Diabetes Technology & Therapeutics 2019;21:S-101-11. [DOI: 10.1089/dia.2019.2508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Janez A, Battelino T, Klupa T, Kocsis G, Kuricová M, Lalić N, Stoian AP, Prázný M, Rahelić D, Šoupal J, Tankova T, Zelinska N. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe. Diabetes Ther 2021;12:3107-35. [PMID: 34694585 DOI: 10.1007/s13300-021-01160-5] [Reference Citation Analysis]
27 Tyndall V, Stimson RH, Zammitt NN, Ritchie SA, McKnight JA, Dover AR, Gibb FW. Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia 2019;62:1349-56. [PMID: 31177314 DOI: 10.1007/s00125-019-4894-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
28 Herbert M, Pendyal S, Rairikar M, Halaby C, Benjamin RW, Kishnani PS. Role of continuous glucose monitoring in the management of glycogen storage disorders. J Inherit Metab Dis 2018;41:917-27. [DOI: 10.1007/s10545-018-0200-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
29 Landau Z, Abiri S, Gruber N, Levy-shraga Y, Brener A, Lebenthal Y, Barash G, Pinhas-hamiel O, Rachmiel M. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience. Acta Diabetol 2018;55:1303-10. [DOI: 10.1007/s00592-018-1218-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
30 Reyes-García R, Mezquita-Raya P, Moreno-Pérez Ó, Muñoz-Torres M, Merino-Torres JF, Márquez Pardo R, Jódar-Gimeno E, Escalada San Martín J, Gargallo-Fernández M, Soto-Gonzalez A, González Pérez de Villar N, Bellido Guerrero D, Gómez-Peralta F, de Luis Román D, López de la Torre Casares M; Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición (SEEN). Executive summary: Position document: Evaluation and management of hypoglycemia in the patient with diabetes mellitus 2020. Diabetes Mellitus Working Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol Diabetes Nutr (Engl Ed) 2021;68:270-6. [PMID: 33422450 DOI: 10.1016/j.endinu.2020.08.007] [Reference Citation Analysis]
31 Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, Hellman R, Lajara R, Roberts VL, Rodbard D, Stec C, Unger J. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract 2021;27:505-37. [PMID: 34116789 DOI: 10.1016/j.eprac.2021.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Majeed W, Thabit H. Closed-loop insulin delivery: current status of diabetes technologies and future prospects. Expert Rev Med Devices 2018;15:579-90. [PMID: 30027775 DOI: 10.1080/17434440.2018.1503530] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
33 Stimson RH, Dover AR, Ritchie SA, Wright RJ, McKnight JA, Zammitt NN, Gibb FW. HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes. BMJ Open Diabetes Res Care 2020;8:e001292. [PMID: 32719078 DOI: 10.1136/bmjdrc-2020-001292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
34 Franco L, Bozzetto L, Angelis R, Calabrese I, Cavagnuolo L, Gasparro T, Riccardi G, Rivellese AA, Annuzzi G. Beneficial effects on body weight of group vs individual care in adults with type 1 diabetes on advanced technologies. Health Sci Rep 2021;4:e385. [PMID: 34622019 DOI: 10.1002/hsr2.385] [Reference Citation Analysis]
35 Vellanki P, Umpierrez GE. Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care 2018;41:1839-41. [PMID: 30135197 DOI: 10.2337/dci18-0004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
36 Dovc K, Battelino T. Evolution of Diabetes Technology. Endocrinol Metab Clin North Am 2020;49:1-18. [PMID: 31980111 DOI: 10.1016/j.ecl.2019.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
37 Charleer S, Gillard P, Vandoorne E, Cammaerts K, Mathieu C, Casteels K. Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well‐controlled youth with type 1 diabetes. Pediatr Diabetes 2020;21:1465-74. [DOI: 10.1111/pedi.13128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Datye KA, Tilden DR, Parmar AM, Goethals ER, Jaser SS. Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes. Curr Diab Rep 2021;21:22. [PMID: 33991264 DOI: 10.1007/s11892-021-01389-1] [Reference Citation Analysis]
39 Mathieu C. Minimising hypoglycaemia in the real world: the challenge of insulin. Diabetologia 2021;64:978-84. [PMID: 33452892 DOI: 10.1007/s00125-020-05354-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Buse JB, Davies MJ, Frier BM, Philis-Tsimikas A. 100 years on: the impact of the discovery of insulin on clinical outcomes. BMJ Open Diabetes Res Care 2021;9:e002373. [PMID: 34400466 DOI: 10.1136/bmjdrc-2021-002373] [Reference Citation Analysis]
41 Pinheiro SL, Bastos M, Barros L, Melo M, Paiva I. Flash glucose monitoring and glycemic control in type 1 diabetes with subcutaneous insulin infusion flash glucose monitoring and glycemic control. Acta Diabetol 2021. [PMID: 34786633 DOI: 10.1007/s00592-021-01827-2] [Reference Citation Analysis]
42 Wright EE, Subramanian S. Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment. Diabetes Technol Ther 2021;23:S12-8. [PMID: 34546082 DOI: 10.1089/dia.2021.0191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Dovc K, Battelino T. Time in range centered diabetes care. Clin Pediatr Endocrinol 2021;30:1-10. [PMID: 33446946 DOI: 10.1297/cpe.30.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
44 El Malahi A, Van Elsen M, Charleer S, Dirinck E, Ledeganck K, Keymeulen B, Crenier L, Radermecker R, Taes Y, Vercammen C, Nobels F, Mathieu C, Gillard P, De Block C. Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus. J Clin Endocrinol Metab 2021:dgab688. [PMID: 34534297 DOI: 10.1210/clinem/dgab688] [Reference Citation Analysis]
45 Edelman SV, Cavaiola TS, Boeder S, Pettus J. Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Prim Care Diabetes 2021;15:199-207. [PMID: 33257275 DOI: 10.1016/j.pcd.2020.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Lameijer A, Lommerde N, Dunn TC, Fokkert MJ, Edens MA, Kao K, Xu Y, Gans ROB, Bilo HJG, van Dijk PR. Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters. Diabetes Res Clin Pract 2021;177:108897. [PMID: 34098059 DOI: 10.1016/j.diabres.2021.108897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Christensen MO, Berg AK, Rytter K, Hommel E, Thyssen JP, Svensson J, Nørgaard K. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes. Diabetes Technol Ther 2019;21:215-21. [PMID: 30943072 DOI: 10.1089/dia.2019.0007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
48 Murata T, Kuroda A, Matsuhisa M, Toyoda M, Kimura M, Hirota Y, Kato K, Sawaki H, Tone A, Kawashima S, Okada A, Watanabe T, Nirengi S, Suganuma A, Sakane N. Predictive Factors of the Adherence to Real-Time Continuous Glucose Monitoring Sensors: A Prospective Observational Study (PARCS STUDY). J Diabetes Sci Technol 2021;15:1084-92. [PMID: 32762345 DOI: 10.1177/1932296820939204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers 2020;6:40. [PMID: 32409703 DOI: 10.1038/s41572-020-0165-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
50 Pietrantonio F, Vinci A, Rosiello F, Alessi E, Pascucci M, Rainone M, Delli Castelli M, Ciamei A, Montagnese F, D'Amico R, Valerio A, Manfellotto D. Green Line Hospital-Territory Study: A Single-Blind Randomized Clinical Trial for Evaluation of Technological Challenges of Continuous Wireless Monitoring in Internal Medicine, Preliminary Results. Int J Environ Res Public Health 2021;18:10328. [PMID: 34639631 DOI: 10.3390/ijerph181910328] [Reference Citation Analysis]
51 Messer LH, Cook PF, Lowe NK, Hood KK, Driscoll KA, Hernandez TL. Predicting optimal use of continuous glucose monitors in adolescents with type 1 diabetes: It's about benefit and burden. J Pediatr Nurs 2021;62:23-9. [PMID: 34861605 DOI: 10.1016/j.pedn.2021.11.016] [Reference Citation Analysis]
52 Kraaijeveld SR. Continuous Glucose Monitoring as a Matter of Justice. HEC Forum. [DOI: 10.1007/s10730-020-09413-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Bode BW, Battelino T, Dovc K. Continuous and Intermittent Glucose Monitoring in 2020. Diabetes Technol Ther 2021;23:S16-31. [PMID: 34061633 DOI: 10.1089/dia.2021.2502] [Reference Citation Analysis]
54 Polonsky WH. Psychosocial Aspects of Diabetes Technology: Adult Perspective. Endocrinol Metab Clin North Am 2020;49:143-55. [PMID: 31980114 DOI: 10.1016/j.ecl.2019.10.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
55 Sayyed Kassem L, Aron DC. The assessment and management of quality of life of older adults with diabetes mellitus. Expert Rev Endocrinol Metab 2020;15:71-81. [PMID: 32176560 DOI: 10.1080/17446651.2020.1737520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Nolan T, Frazzitta M. Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective. Diabetes Technol Ther 2021;23:S28-35. [PMID: 34546078 DOI: 10.1089/dia.2021.0262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Ehrmann D, Priesterroth L, Schmitt A, Kulzer B, Hermanns N. Associations of Time in Range and Other Continuous Glucose Monitoring-Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends. Diabetes Spectr 2021;34:149-55. [PMID: 34149255 DOI: 10.2337/ds20-0096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Marks BE, Wolfsdorf JI. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:128. [PMID: 32256447 DOI: 10.3389/fendo.2020.00128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
59 Lavens A, Nobels F, De Block C, Oriot P, Verhaegen A, Chao S, Casteels K, Mouraux T, Doggen K, Mathieu C; Belgian Group of Experts IQED and IQECAD. Effect of an Integrated, Multidisciplinary Nationwide Approach to Type 1 Diabetes Care on Metabolic Outcomes: An Observational Real-World Study. Diabetes Technol Ther 2021;23:565-76. [PMID: 33780640 DOI: 10.1089/dia.2021.0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Scharf J, Nguyen XQ, Vu-Eickmann P, Krichbaum M, Loerbroks A. Perceived Usefulness of Continuous Glucose Monitoring Devices at the Workplace: Secondary Analysis of Data From a Qualitative Study. J Diabetes Sci Technol 2019;13:242-7. [PMID: 30027749 DOI: 10.1177/1932296818789143] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
61 Shi L, Fonseca V, Childs B. Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. J Diabetes Complications 2021;35:107916. [PMID: 33836965 DOI: 10.1016/j.jdiacomp.2021.107916] [Reference Citation Analysis]
62 Deiss D, Szadkowska A, Gordon D, Mallipedhi A, Schütz-Fuhrmann I, Aguilera E, Ringsell C, De Block C, Irace C. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System. Diabetes Technol Ther 2019;21:254-64. [PMID: 31021180 DOI: 10.1089/dia.2018.0397] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
63 Dovc K, Battelino T. New technical approach to the diabetes therapy. Minerva Pediatr 2020;72:263-77. [PMID: 32418412 DOI: 10.23736/S0026-4946.20.05865-X] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Burckhardt M, Abraham MB, Mountain J, Coenen D, Paniora J, Clapin H, Jones TW, Davis EA. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring. Diabetes Technology & Therapeutics 2019;21:575-80. [DOI: 10.1089/dia.2019.0149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
65 Vallarino CR, Wong-Jacobson SH, Benneyworth BD, Meadows ES. Costs and Outcomes Comparison of Diabetes Technology Usage Among People With Type 1 or 2 Diabetes Using Rapid-Acting Insulin. J Diabetes Sci Technol 2021;:19322968211052081. [PMID: 34654339 DOI: 10.1177/19322968211052081] [Reference Citation Analysis]